PUBLIC COMPANY
save$AYTUAYTU BIOPHARMA, INC
$AYTU2.2300-0.89%Denver, CO, USupdated 1mo ago
community read0 votes
pipeline
4
marketed
4
phase 3
0
catalysts ytd
1
approvals ytd
1
recalls ytd
0
Pipeline(4)
pipeline depth4 products
4Marketed
Marketed
METADATE CD
Sodium-dependent dopamine transporterSodium-dependent noradrenaline transporter
Marketedamfetamine XR-ODT
Attention Deficit Hyperactivity Disorder (ADHD)
Marketedcarbinoxamine maleate ER
Allergic Conjunctivitis
Marketedmethylphenidate hydrochloride XR-ODT
Attention Deficit Hyperactivity Disorder (ADHD)
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase4ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity Disorder
- —A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0
- phase3Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that